AdvanCell

Website

Operator of a radiopharmaceutical company intended for developing alpha therapies for cancer patients. The company develops alpha-emitting isotopes attached to molecules that deliver cytotoxic radiati...

Healthcare
Sydney, Australia
Founded 2019
76 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$132.3M
Last Round
N/A
Investors
+18 other investors
View all 18 investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock AdvanCell's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required